Stock Screener App

Gratuito -

Installare

Medical Devices

89.22

0.57% -0.51

after-market

Dopo l'orario di chiusura: 89.31 0.09 +0.10%

Medtronic Plc (MDT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Medtronic Plc Borsa (MDT) Ultime notizie

Medtronic gets CE mark for robot-driven vessel-sealing device - MedTech Dive

Baird Adjusts Medtronic Price Target to $94 From $92, Maintains Neutral Rating - MarketScreener

Morgan Stanley Adjusts Medtronic Price Target to $107 From $98, Maintains Overweight Rating - MarketScreener

Medtronic : first in the U.S. to offer 400 cm 0.018” peripheral guidewire for transradial access - MarketScreener

Medtronic (MDT) Price Target Raised by Morgan Stanley | MDT Stoc - GuruFocus

Medtronic shaping future of surgery, secures CE Mark for LigaSure™ technology on Hugo™ robotic-assisted surgery system - Medtronic

Medtronic (MDT) Experiences Increased Bearish Options Activity | MDT Stock News - GuruFocus

Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships - Yahoo Finance

Medtronic Stock Is Climbing Friday: What's Going On?Medtronic (NYSE:MDT) - Benzinga

Medtronic (MDT) Stock Insights and Investment Tools | MDT Stock News - GuruFocus

Medtronic (MDT) Gains from CMS Proposal on Renal Denervation Coverage | MDT Stock News - GuruFocus

Medtronic Says Centers for Medicare & Medicaid Services Proposes National Coverage for Blood Pressure Treatment Device - MarketScreener

Unusual Options Activity Noticed for Medtronic (MDT) | MDT Stock News - GuruFocus

Medtronic (MDT) Gains Following Medicare's Review of New Hypertension Technology | MDT Stock News - GuruFocus

William Blair reiterates Market Perform rating on Medtronic stock after CMS proposal - Investing.com

Medtronic, Recor praise new CMS coverage for renal denervation - MassDevice

The Best High Yield Medical Device Stock to Invest $1,000 in Right Now - The Motley Fool

Medtronic : issues statement on the U.S. Centers for Medicare & Medicaid Services proposed National Coverage Determination for Symplicity Spyral™ renal denervation (RDN) system - MarketScreener

Citi Analyst Boosts Medtronic (MDT) Price Target to $99 | MDT Stock News - GuruFocus

Needham Keeps Hold Rating on Medtronic (MDT) Amid Spin-Off News - MSN

Medtronic (MDT) Gains As Market Dips: What You Should Know - Yahoo Finance

Medtronic names CFO for diabetes spinoff - MedTech Dive

Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone companyJul 8, 2025 - Medtronic

Why Is Merit Medical Stock Trading Higher On Tuesday?Merit Medical Systems (NASDAQ:MMSI) - Benzinga

Medtronic Forges Ahead With Innovative Therapies - Morningstar

Those Who Invested in Medtronic (NYSE:MDT) a Year Ago Are up 19% - 富途牛牛

Medtronic’s SWOT analysis: stock poised for growth amid challenges - Investing.com

Wolfe Research Upgrades Medtronic (MDT) to Peer Perform - Insider Monkey

Why Medtronic is a Top 25 Dividend Giant (MDT) - Nasdaq

Medtronic: Cash Flow Strength Balanced By Execution Risks (NYSE:MDT) - Seeking Alpha

Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology - Medtronic

Medtronic appoints new general counsel from another large medtech company - MassDevice

Tennis star Alexander Zverev partners with Medtronic to raise Diabetes awareness - Medical Device Network

Medtronic: Margin Inflection With Diabetes SpinKey Drivers (NYSE:MDT) - Seeking Alpha

Medtronic (MDT) Appoints Dr. Joon Sup Lee to Board of Directors - Yahoo

Medtronic's Trading Volume Drops 43.49% Ranking 152nd in Market - AInvest

What Makes Medtronic a Leader in Medical Devices - Yahoo Finance

Medtronic Stock Rated Outperform as Renal Denervation and Spin-Off Drive Growth Potential - Insider Monkey

Early Alert: Esophageal pH Monitoring Capsule Issue from Medtronic - fda.gov

Healthcare Tech Leader Medtronic Appoints Emory CEO Dr. Lee to Board: Brings $7.7B Healthcare System Expertise - Stock Titan

Medtronic plc SEC 10-K Report - TradingView

Medtronic Diabetes and tennis pro Alexander Zverev join forces to champion life without limits for people with diabetes - Medtronic

Medtronic training pact includes Hugo robot, cardiac ablation tech - MedTech Dive

Medtronic stock has significant opportunity in renal denervation, RBC says By Investing.com - Investing.com UK

FDA Clears Minimally Invasive Laser Ablation System from Medtronic for Epilepsy & Brain Tumors - Medical Device and Diagnostic industry

Medtronic partners with IRCAD on Hugo, Affera surgical training - MassDevice

Medtronic to invest $50 million over five years in Pune GCC - BusinessLine

Medtronic : IRCAD North America and Medtronic announce collaboration to advance surgical training and innovation - MarketScreener

Surgical Retractors Market Top Companies StudyMedtronic Plc, - openPR.com

Medtronic to invest $50 million over 5 years in Pune - PUNE PULSE

Medtronic plc Stock MDT Using Cash Flow Model NYSE Composite - Kalkine Media

A Look At The Fair Value Of Medtronic plc (NYSE:MDT) - simplywall.st

Medtronic to invest $50 million over 5 years in New Diabetes Global Capability Centre in Pune - Punekar News

Medtronic Invests $50M in Pune Diabetes Center - Rediff MoneyWiz

Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings - Investing.com Nigeria

Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings By Investing.com - Investing.com South Africa

Leerink Partners Initiates Coverage on Medtronic (MDT) with Outperform Rating | MDT Stock News - GuruFocus

Medtronic (MDT) Positioned for Growth Amid Strategic Shifts | MDT Stock News - GuruFocus

Leerink Partners Initiates Medtronic at Outperform With $110 Price Target - MarketScreener

Medtronic: Solid Recent Performance But Better Options Available (NYSE:MDT) - Seeking Alpha

Medtronic Doubles Down on Innovation as Cardiovascular Tech Takes Center Stage! - Smartkarma

Medtronic’s SWOT analysis: stock outlook amid diabetes spin-off and RDN growth - Investing.com

Medtronic separate diabetes business to be called MiniMed - MSN

FDA approves Medtronic Omniasecure defib lead - BioWorld MedTech

Medtronic Plc. (NYSE: MDT) To Separate Its Diabetes Business - Smartkarma

Earnings Preview: What To Expect From Medtronic’s Report - MSN

SYK

$390.59

0.22%

BSX

$103.48

0.81%

EW

$76.81

1.88%

GEHC

$74.39

0.08%

DXCM

$84.78

0.64%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters